Electronic PNDF User’s Guide
The electronic PNDF is a
software application or program designed to run on handheld computers (also
called personal digital assistants or PDAs) operating under the Palm OS. It contains the information obtained from
the printed version of the Philippine National Drug Formulary 5th
edition and allows the user to retrieve and display it on the screen of a PDA.
The electronic PNDF is
the product of a research project entitled “A Survey of Physicians’
Experience Using an Electronic Version of the Philippine National Drug Formulary
(PNDF) for Handheld Computers”. The
project is being conducted by a team of investigators from the National Drug
Information Center and the Medical Informatics Unit of the University of the
Philippines Manila College of Medicine with the support of the National
Institutes of Health. The aim of the
study is to determine if an electronic version of the PNDF developed by the
investigators would be functional and have a positive impact on physician
behavior for information-seeking and decision-making, his efficiency in
conducting his practice, as well as on overall patient care. Data would be obtained from a
cross-sectional survey on medical students and physicians who are already
familiar with the operation of handheld computers running under the Palm OS
platform after using a beta-version of the program. This data will then be used
to further enhance the electronic PNDF software program.
Ultimately, the
electronic PNDF project aims to provide adequate, up-to-date and easy-to-use
drug information for physicians and other health professionals. A recent study presented to the American
Medical Informatics Association revealed that the use of a drug information
database for handheld computers running the Palm OS could result in a
significantly lesser number of medication errors committed by physicians. The electronic PNDF, which currently
provides the routes of administration and formulation of essential drugs, can
possibly prevent medication errors if it also contained additional drug
information such as dosages and adverse effects. Other data that would also most likely be helpful are brand names
and retail prices. Future versions of
the software program are now being designed to address these identified needs.